Bioworld Financial Watch articles from February 2005

Bioworld Financial Watch archives from February 2005

Northwest Biotherapeutics' cancer effort still kicking.(Toucan Capital Brings Firm Back From Brink)
February 7, 2005... When company officials from Northwest Biotherapeutics Inc. met with would-be financiers from Toucan Capital II LP at 2004's JPMorgan Healthcare Conference, NBI was "quite literally a week from closing its doors," recalled Alton Boynton,...

10 biggest U.S. gainers for the week.
February 7, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Northwest BioThera 475.00 Icoria 35.19 Aphton 29.66 Martek Bio 26.63 Immtech 25.58 Cerus Corp. 21.21...

10 biggest U.S. losers for the week.
February 7, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Imcor -23.08 Xcyte Therapies -20.00 Discovery Labs -19.12 XOMA -16.67 Emisphere -12.82 Pharmos -11.00 Biotime ...

Public financing of biotechnology: January 2005.
February 7, 2005... Public Financing Of Biotechnology: January 2005 I. COMMENCED TRADING IN JANUARY Company Date Date Shares/ (Symbol) (#) Filed Comm. Units (M) Price INITIAL OFFERINGS Narhex Life ...

Other financings of public biotechnology companies: January 2005.
February 7, 2005... Other Financings Of Public Biotechnology Companies: January 2005 TOTAL: $744.88M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: January 2005.
February 7, 2005... Venture Capital And Corporate Investments In Biotechnology Companies: January 2005 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $406.25M Company Location Date Amt. (M) Adenosine ...

BioWorld stock report for public biotechnology companies.
February 7, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Close Close Vol Company Symbol 1/28 2/4 ...

Money raised by Biotech In 2005: January.
February 7, 2005... Money Raised By Biotech In 2005: January Type of financing Jan. Total ($M) Public offerings 585.73 585.73 Private biotechs 406.25 406.25 Public/other 744.88 744.88...

Canadian companies needing mid-level funds might try U.S.(Wangling With Border Issues)
February 14, 2005... VANCOUVER, British Columbia -- For maturing Canadian biotech firms, an inherent financing difficulty is the lack of available mezzanine-level funding in their country. Although that can be overcome by attracting U.S. venture capitalists, that...

10 Biggest U.S. gainers for the week.
February 14, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Ergo Science 24.43 Myogen 17.39 Emisphere 15.42 Peregrine Pharma 14.05 Tercica 13.70 Trimeris 12.86 Vicuron 12.69...

10 Biggest U.S. losers for the week.
February 14, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Axonyx -63.71 Inspire Pharma -43.42 Oxis Int'l -28.65 Compugen -22.79 Maxim Pharma -18.70 Aastrom Biosci -18.54 Aradigm ...

Clinical trials update: January 2005.
February 14, 2005... Clinical Trials Update: January 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Barrier Rambazole Oral retinoic acid Therapeutics ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: January 2005.
February 14, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: January 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel ...

FDA submissions, approvals and other actions: January 2005.
February 14, 2005... FDA Submissions, Approvals And Other Actions: January 2005 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Immunomedics Epratuzumab Humanized anti-CD22 Lupus...

BioWorld stock report for public biotechnology companies.
February 14, 2005... % Change Company Symbol Close Close Vol 2/4 2/11 WK YTD (000) Aastrom Biosci ASTM 3.56...

Fewer blockbuster drugs on tap for approval this year.
February 21, 2005... "Miracle drug" is not a phrase bandied about lightly in biotechnology, but when key data for Avastin (bevacizumab), the antibody for colorectal cancer from Genentech Inc., were unveiled at the American Society of Clinical Oncology annual...

10 biggest U.S. gainers for the week.
February 21, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Deltagen 80.00 Cerus Corp. 20.31 Aeolus 19.72 Tercica 17.61 Senomyx 16.84 Immtech 14.21 Exact Sciences 13.58...

10 biggest U.S. losers for the week.
February 21, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Aphton -51.31 Neose Technol -26.22 Boston Life -20.16 ViroPharma -20.00 InKine Pharma -16.91 Pharsight -15.66...

Correction.(Correction Notice)
February 21, 2005... An item in the Feb. 14, 2005, issue of BioWorld Financial Watch should have said the FDA granted Neurobiological Technologies Inc.'s Viprinex fast-track (not orphan) status for use in ischemic stroke. Editor's Note: The correction has been...

Biotechnology company deals with other biotechnology companies: collaborations and agreements, Nov. 18, 2004-Feb. 16, 2005.
February 21, 2005... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations And Agreements, Nov. 18, 2004-Feb. 16, 2005 Company * Company * Type/Product Area (Country; (Country; Symbol) ...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, Nov. 18, 2004-Feb. 16, 2005.
February 21, 2005... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Nov. 18, 2004-Feb. 16, 2005 Company * Company Type/Product Area (Country; Symbol) Affymetrix ...

Manufacturing, marketing and distribution agreements between biotech companies: Nov. 18, 2004-Feb. 16, 2005.
February 21, 2005... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Nov. 18, 2004-Feb. 16, 2005 Company * Company * Product (Country; (Country; Symbol) Symbol) Angel ...

Biotech--biotech collaborations: modified and terminated agreements, Nov. 18, 2004-Feb. 16, 2005.
February 21, 2005... Biotech--Biotech Collaborations: Modified And Terminated Agreements, Nov. 18, 2004-Feb. 16, 2005 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement...

BioWorld stock report for public biotechnology companies.
February 21, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 2/11 2/18 ...

BIO chief brings 'passion,' political savvy to new job.
February 28, 2005... NEW YORK -- At the seventh annual BIO CEO & Investor Conference, about 2,000 registrants got their first taste of the powerhouse trade association's new leader, former U.S. Rep. James Greenwood, who delivered a keynote luncheon speech in which...

10 biggest U.S. gainers for the week.
February 28, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent)(By Dollars) Valentis 23.13 Pharsight 21.43 Avax Technol 20.69 Metabasis 16.95 Argonaut 16.67 Connetics Corp. 14.91 Immunicon ...

10 biggest U.S. losers for the week.
February 28, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) EntreMed -27.50 NeoRx Corp. -20.48 Imcor -20.00 Alteon -19.19 Neurochem -18.99 Third Wave Tech -17.86 Biomira -16.79...

Biotech-big pharma collaborations: new agreements, Dec. 16, 2004-Feb. 23, 2005 (#).
February 28, 2005... Biotech-Big Pharma Collaborations: New Agreements, Dec. 16, 2004-Feb. 23, 2005 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Addex Ortho-McNeil ...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: Dec. 16, 2004-Feb. 23, 2005 (#).
February 28, 2005... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Dec. 16, 2004-Feb. 23, 2005 (#) Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) ...

Biotech--big pharma collaborations: modified and terminated agreements, Dec. 16, 2004-Feb. 23, 2005 (#).
February 28, 2005... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, Dec. 16, 2004-Feb. 23, 2005 (#) I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) ...

BioWorld stock report for public biotechnology companies.
February 28, 2005... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 2/18 2/25 WK YTD (000) Aastrom Biosci ASTM 3.05 ...